BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Feb 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-02-03

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-03	Common Stock	M	10000	$21.51	Acquired	338530	Direct
2020-02-03	Common Stock	S	10000	$83.5	Disposed	328530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-03	Stock Option (Right to buy Common Stock)	$21.51	M	10000	Disposed	2020-05-11	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	180261	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.